Chris Chalk, Neal Huff Cast in When I Come to Die for LCT3; Thomas Kail Directs | Playbill

Related Articles
News Chris Chalk, Neal Huff Cast in When I Come to Die for LCT3; Thomas Kail Directs Chris Chalk, who last appeared opposite Denzel Washington in the Broadway revival of Fences, will star in the LCT3 world premiere of Nathan Louis Jackson's When I Come to Die Off-Broadway.

//assets.playbill.com/editorial/23ea0d5325e4e197b5ba914845270b11-chalk200.jpg
Chris Chalk Photo by Joseph Marzullo/WENN

Chalk is cast as Damon Robinson, a death-row inmate who is faced with questions about faith and hope when he survives a lethal injection. Tony Award-nominated director Thomas Kail (In the Heights, Lombardi) will direct When I Come to Die, which will run Jan. 31-Feb 26 at the Duke on 42nd Street. An official opening has been set for Feb. 10.

The cast will also feature Michael Balderrama (In the Heights), Neal Huff (Take Me Out), David Patrick Kelly (Festen) and Amanda Mason Warren (The Golden Age).

The production will have set design by Robin Vest, costume design by Emily Rebholz, lighting design by Betsy Adams and sound design by Jill BC DuBoff.

When I Come to Die reunites playwright Jackson and director Kail. The two collaborated on the world premiere of Broke-ology at the Williamstown Theatre Festival and for LCT in 2009.

All tickets for LCT3 productions are priced $20. For tickets phone (646) 223-3010 or visit Dukeon42.

Visit LincolnCenterTheater.

*

Citing the need to develop strong relationships with new artists and to develop a new audience, and recognizing the frustrations that playwrights have with the current system of readings and workshops, Lincoln Center Theater (under the direction of artistic director Andre Bishop and executive producer Bernard Gersten) created LCT3 to offer new artists fully staged productions. Paige Evans is the director of LCT3.

 
RELATED:
Today’s Most Popular News:
 X

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting playbill.com with your ad blocker.
Thank you!